Delivery Order SPE2DB24D2109-SPE2DB25FHXYE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,097.68 on April 30, 2025, for the supply of Advair 250-50 Diskus 60 count inhalers, with completion scheduled for May 1, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order valued at $2,911.44 to AmerisourceBergen Drug Corp for Advair 500-50 Diskus 60s pharmaceutical product, with an ultimate completion date of August 18, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $3,078.00 to AmerisourceBergen Drug Corp for Advair 250-50 Diskus 60-count inhalers under a firm fixed-price contract type. The award was issued on September 25, 2025, with an ultimate completion date of September 26, 2025, and was not set aside for any socioeconomic category. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order is...
- This is a $7,859.14 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the pharmaceutical product Advair 500-50 Diskus 60s, and has a completion date of July 25, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, holding several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,586.85 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 microgram inhalers (12-gram units). This firm fixed price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $7,838.23 by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Advair HFA 115-21 mcg inhaler in 12-gram units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 5, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair 250-50 Diskus 60s, a respiratory medication. The $4,435.74 firm fixed-price contract has a completion date of September 8, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $6,460.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Advair HFA 115-21 mcg inhaler 12gm units, with an ultimate completion date of July 21, 2025. This delivery order represents a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a $2,618.19 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhaler (12 grams) on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,758.69 firm fixed-price contract is for the supply of Advair 100-50 Diskus, a respiratory medication, to support military healthcare programs. The contract has an ultimate completion date of March 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXYEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,594.88 to AmerisourceBergen Drug Corp for the supply of Advair 250-50 Diskus 60-count units. This competitively awarded, firm fixed-price contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026, which enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company holds an extensive portfolio of federal contracts covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a non-set-aside award, this delivery order reflects AmerisourceBergen's demonstrated capability to compete successfully in the federal marketplace and fulfill Defense Logistics Agency medical supply requirements that support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/22/25 |